In the US, there are ~30,000 small MedTech/Biotech/Pharma entities. How many are efficiently capturing non-dilutive funding (NDF) to complement their private raise? Not enough.With $25B annually in biomedical R&D NDF from the DoD and other non-NIH Federal agencies, this is an opportunity for dual-use (military and civilian) tech.Universities dominate NIH's $26B/yr funding world and ~80% of CDMRP's $1.6B/yr early-stage funding goes to academia. For under-resourced small businesses, competing for NIH, CDMRP, and DoD NDF can be challenging because:1. You’re already wearing too many hats.2. You’re unfamiliar with DoD/Fed NDF terminology, processes, and contracting.3. You don't have the time to learn DoD/Fed entry points and map how to repeatedly capture NDF.Many companies have tried submitting to DoD/Fed mechanisms with varied success. Maybe you:• Submitted to the MRDC BAA, only to never hear back; • Submitted to an OSD- or BARDA-sponsored consortia and were not selected;• Completed a CDMRP app and didn’t make it to programmatic review due to a single section.While there are numerous NIH funding assist companies, if you’re interested in pursuing DoD/Fed NDF, we should talk.What if…• You had military- and medical-(MILMED)connected personnel on your team providing clinical/op medicine guidance?• You had early end-user buy-in to ensure product-market fit?• You understood DoD/Fed entry points and follow-on funding paths?• You received innovation guidance (e.g., TRL, AI-assist, comm, cyber, DCAA, field use evals, op demos)?• You had an interpreter for MILMED acronyms, processes, and clear instruction on the narrative reviewers need to see?• You knew which conferences were worth attending?How valuable would that be to you and your company? We have dozens of value add examples. Let’s combine your tech/team with our expertise, experience, and connections to get started. Here’s what we can do for you:1. Strategic Roadmaps (SR): Quarterly prioritized listings of tactical/strategic NDF opps and DoD PI connections.2. NDF Applications: Clinical/op med guidance, military narrative (e.g., impact, future funding), end-user buy-in/DoD connections, templates, and more. We’ve worked with >250; helped to capture >$300M (3,500X ROI for a small molecule; >500X for medtech).3. Advisory Services: We’ve advised >20 companies. 4. R&D Dashboards: SR plus expanded DoD PI connections, monthly advising, CRADA locations, conference/industry day info, R&D and competitor assessments, more R&D resources.Please connect via "Book an Appointment" or send me a DM.
Listed skills include Clinical Research, Public Health, Biotechnology, Medicine, and 44 others.